[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (22)

Search Parameters:
Keywords = fluids osmolarity

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
19 pages, 2334 KiB  
Article
Accumulation of Cerebrospinal Fluid, Ventricular Enlargement, and Cerebral Folate Metabolic Errors Unify a Diverse Group of Neuropsychiatric Conditions Affecting Adult Neocortical Functions
by Lena Ikeda, Adrià Vilaseca Capel, Dhruti Doddaballapur and Jaleel Miyan
Int. J. Mol. Sci. 2024, 25(18), 10205; https://doi.org/10.3390/ijms251810205 - 23 Sep 2024
Viewed by 731
Abstract
Cerebrospinal fluid (CSF) is a fluid critical to brain development, function, and health. It is actively secreted by the choroid plexus, and it emanates from brain tissue due to osmolar exchange and the constant contribution of brain metabolism and astroglial fluid output to [...] Read more.
Cerebrospinal fluid (CSF) is a fluid critical to brain development, function, and health. It is actively secreted by the choroid plexus, and it emanates from brain tissue due to osmolar exchange and the constant contribution of brain metabolism and astroglial fluid output to interstitial fluid into the ventricles of the brain. CSF acts as a growth medium for the developing cerebral cortex and a source of nutrients and signalling throughout life. Together with perivascular glymphatic and interstitial fluid movement through the brain and into CSF, it also acts to remove toxins and maintain metabolic balance. In this study, we focused on cerebral folate status, measuring CSF concentrations of folate receptor alpha (FOLR1); aldehyde dehydrogenase 1L1, also known as 10-formyl tetrahydrofolate dehydrogenase (ALDH1L1 and FDH); and total folate. These demonstrate the transport of folate from blood across the blood–CSF barrier and into CSF (FOLR1 + folate), and the transport of folate through the primary FDH pathway from CSF into brain FDH + ve astrocytes. Based on our hypothesis that CSF flow, drainage issues, or osmotic forces, resulting in fluid accumulation, would have an associated cerebral folate imbalance, we investigated folate status in CSF from neurological conditions that have a severity association with enlarged ventricles. We found that all the conditions we examined had a folate imbalance, but these folate imbalances were not all the same. Given that folate is essential for key cellular processes, including DNA/RNA synthesis, methylation, nitric oxide, and neurotransmitter synthesis, we conclude that ageing or some form of trauma in life can lead to CSF accumulation and ventricular enlargement and result in a specific folate imbalance/deficiency associated with the specific neurological condition. We believe that addressing cerebral folate imbalance may therefore alleviate many of the underlying deficits and symptoms in these conditions. Full article
(This article belongs to the Section Molecular Neurobiology)
Show Figures

Figure 1

Figure 1
<p>Total protein content of CSF from different neurological conditions. Bars show mean with standard error bar. The proteins values are absolute values, mg/mL, of CSF. Most values are not significantly different from control values. MS, live dementia, IIH, and NPH are all significantly reduced. BP and SCZ are also reduced but not significantly with the number of samples in the study. Data were normalised using the general control sample (non-demented control, 1994-076) added to every Western blot and dot blot. This control sample was set as 1, and measurements from other CSF samples were adjusted according to their intensity relative to the control, including all controls used. * indicates significance at <span class="html-italic">p</span> ≤ 0.05, **** indicates significance at <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 2
<p>Relative (to the control) concentration of folate in CSF from the different neurological conditions. Epilepsy is not different from control, but PDC, PD, BP, and SCZ all show a non-significant decrease, while MS, AD, live dementia, IIH, and NPH all show significantly reduced folate levels. TBI is unique in showing a significantly increased folate concentration in CSF. Data were normalised using the general control sample (non-demented control, 1994-076) added to every Western blot and dot blot. This control sample was set as 1, and measurements from other CSF samples were adjusted according to their intensity relative to the control, including all controls. * indicates significance at <span class="html-italic">p</span> ≤ 0.05, ** indicates significance at <span class="html-italic">p</span> ≤ 0.01, *** indicates significance at <span class="html-italic">p</span> ≤ 0.001.</p>
Full article ">Figure 3
<p>Relative (to the control) concentration of folate receptor alpha (FOLR1) in CSF from the different neurological conditions. All conditions show significantly reduced FOLR1 levels with barely detectable levels in the LP CSF of live dementia, IIH, and NPH. Bars are means plus SEM. Data were normalised using the general control sample (non-demented control, 1994-076) added to every Western blot and dot blot. This control sample was set as 1, and measurements from other CSF samples were adjusted according to their intensity relative to the control, including all controls used. * indicates significance at <span class="html-italic">p</span> ≤ 0.05, *** indicates significance at <span class="html-italic">p</span> ≤ 0.001 **** indicates significance at <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 4
<p>Relative (to the control) concentration of FDH in CSF from the different neurological conditions. Epilepsy, PDC, PD TBI, MS, and moderate AD have no significant difference from control levels of FDH in CSF. BP, SCZ, and severe AD have significantly reduced levels of FDH in CSF, while live dementia, IIH, and NPH have barely detectable levels in LP CSF. Bars are means plus SEM. Data were normalised using the general control sample (non-demented control, 1994-076) added to every Western blot and dot blot. This control sample was set as 1, and measurements from other CSF samples were adjusted according to their intensity relative to the control, including all controls used. * indicates significance at <span class="html-italic">p</span> ≤ 0.05, *** indicates significance at <span class="html-italic">p</span> ≤ 0.001 **** indicates significance at <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 5
<p>Schematic diagram (created using <a href="http://BioRender.com/o82e774" target="_blank">BioRender.com/o82e774</a>) illustrating proposed route of folate supply to the cerebral cortex. Folate is transported in blood, within erythrocytes and plasma bound to FOLR1 and folate-binding proteins. In the choroid plexus, fenestrated capillaries allow FOLR1 and free folate (and other blood components) to enter the interstitial space on the basal side of the choroid epithelium. Here, membrane-bound FOLR1 accepts free folate, while folate bound to FOLR1 inserts into the membrane. FOLR1 then invaginates to release folate into the cell and then merges with the apical membrane to produce vesicles containing FOLR1 and folate that are sent into the CSF. FDH is synthesised in radial glial and astroglial cells that send vesicles of FDH into the CSF. These fuse with the FOLR1–folate vesicles to transfer folate from FOLR1 to FDH. FDH–folate can then enter the cortex through the GFAP-negative–FDH-positive astroglial network. Folate may also enter directly from CSF into CSF-contacting neurons. Folate is transported around the CSF pathway as free folate and bound to FDH, and this is important to supply the grey matter with folate through the subarachnoid CSF and pial interface as well as the meninges.</p>
Full article ">Figure 6
<p>Venn diagram illustrating the changes in FOLR1, folate, and FDH concentrations in the CSF of the conditions investigated in this study. No condition was normal. PDC, PD, epilepsy, and TBI had reduced FOLR1 but normal FDH and folate, indicating normal folate transport into the CSF but that folate may be entering the brain with FOLR1 rather than FDH, as we have described in severe AD [<a href="#B28-ijms-25-10205" class="html-bibr">28</a>]. Bipolar and SCZ have reduced FDH and FOLR1 but normal folate, suggesting a problem regarding transport into CSF, as well as into the brain. Moderate AD and MS have reduced folate and FOLR1, indicating a significant obstruction to folate transport into the CSF. IIH, NPH, live dementia, and severe AD have a reduction in all three molecules, indicating a profound cerebral folate deficiency. The table indicates the number of cases analysed for each condition.</p>
Full article ">
20 pages, 1100 KiB  
Systematic Review
Antenatal Determinants of Postnatal Renal Function in Fetal Megacystis: A Systematic Review
by Ugo Maria Pierucci, Irene Paraboschi, Guglielmo Mantica, Sara Costanzo, Angela Riccio, Giorgio Giuseppe Orlando Selvaggio and Gloria Pelizzo
Diagnostics 2024, 14(7), 756; https://doi.org/10.3390/diagnostics14070756 - 2 Apr 2024
Viewed by 1279
Abstract
Introduction: To evaluate the clinical usefulness of demographic data, fetal imaging findings and urinary analytes were used for predicting poor postnatal renal function in children with congenital megacystis. Materials and methods: A systematic review was conducted in MEDLINE’s electronic database from [...] Read more.
Introduction: To evaluate the clinical usefulness of demographic data, fetal imaging findings and urinary analytes were used for predicting poor postnatal renal function in children with congenital megacystis. Materials and methods: A systematic review was conducted in MEDLINE’s electronic database from inception to December 2023 using various combinations of keywords such as “luto” [All Fields] OR “lower urinary tract obstruction” [All Fields] OR “urethral valves” [All Fields] OR “megacystis” [All Fields] OR “urethral atresia” [All Fields] OR “megalourethra” [All Fields] AND “prenatal ultrasound” [All Fields] OR “maternal ultrasound” [All Fields] OR “ob-stetric ultrasound” [All Fields] OR “anhydramnios” [All Fields] OR “oligohydramnios” [All Fields] OR “renal echogenicity” [All Fields] OR “biomarkers” [All Fields] OR “fetal urine” [All Fields] OR “amniotic fluid” [All Fields] OR “beta2 microglobulin” [All Fields] OR “osmolarity” [All Fields] OR “proteome” [All Fields] AND “outcomes” [All Fields] OR “prognosis” [All Fields] OR “staging” [All Fields] OR “prognostic factors” [All Fields] OR “predictors” [All Fields] OR “renal function” [All Fields] OR “kidney function” [All Fields] OR “renal failure” [All Fields]. Two reviewers independently selected the articles in which the accuracy of prenatal imaging findings and fetal urinary analytes were evaluated to predict postnatal renal function. Results: Out of the 727 articles analyzed, 20 met the selection criteria, including 1049 fetuses. Regarding fetal imaging findings, the predictive value of the amniotic fluid was investigated by 15 articles, the renal appearance by 11, bladder findings by 4, and ureteral dilatation by 2. The postnatal renal function showed a statistically significant relationship with the occurrence of oligo- or anhydramnion in four studies, with an abnormal echogenic/cystic renal cortical appearance in three studies. Single articles proved the statistical prognostic value of the amniotic fluid index, the renal parenchymal area, the apparent diffusion coefficient (ADC) measured on fetal diffusion-weighted MRI, and the lower urinary tract obstruction (LUTO) stage (based on bladder volume at referral and gestational age at the appearance of oligo- or anhydramnios). Regarding the predictive value of fetal urinary analytes, sodium and β2-microglobulin were the two most common urinary analytes investigated (n = 10 articles), followed by calcium (n = 6), chloride (n = 5), urinary osmolarity (n = 4), and total protein (n = 3). Phosphorus, glucose, creatinine, and urea were analyzed by two articles, and ammonium, potassium, N-Acetyl-l3-D-glucosaminidase, and microalbumin were investigated by one article. The majority of the studies (n = 8) failed to prove the prognostic value of fetal urinary analytes. However, two studies showed that a favorable urinary biochemistry profile (made up of sodium < 100 mg/dL; calcium < 8 mg/dL; osmolality < 200 mOsm/L; β2-microglobulin < 4 mg/L; total protein < 20 mg/dL) could predict good postnatal renal outcomes with statistical significance and urinary levels of β2-microglobulin were significantly higher in fetuses that developed an impaired renal function in childhood (10.9 ± 5.0 mg/L vs. 1.3 ± 0.2 mg/L, p-value < 0.05). Conclusions: Several demographic data, fetal imaging parameters, and urinary analytes have been shown to play a role in reliably triaging fetuses with megacystis for the risk of adverse postnatal renal outcomes. We believe that this systematic review can help clinicians for counseling parents on the prognoses of their infants and identifying the selected cases eligible for antenatal intervention. Full article
(This article belongs to the Special Issue Kidney Disease: Biomarkers, Diagnosis, and Prognosis: 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Flow Diagram.</p>
Full article ">
16 pages, 1504 KiB  
Review
The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients
by Carl Randall Harrell, Lisa Feulner, Valentin Djonov, Dragica Pavlovic and Vladislav Volarevic
Cells 2023, 12(23), 2755; https://doi.org/10.3390/cells12232755 - 1 Dec 2023
Cited by 2 | Viewed by 4176
Abstract
Dry eye disease (DED) is a multifactorial disorder of the lacrimal system and ocular surface, characterized by a deficiency in the quality and/or quantity of the tear fluid. The multifactorial nature of DED encompasses a number of interconnected underlying pathologies, including loss of [...] Read more.
Dry eye disease (DED) is a multifactorial disorder of the lacrimal system and ocular surface, characterized by a deficiency in the quality and/or quantity of the tear fluid. The multifactorial nature of DED encompasses a number of interconnected underlying pathologies, including loss of homeostasis, instability and hyperosmolarity of the tears, and the induction and propagation of detrimental inflammatory responses in the eyes, which finally results in the development of neurosensory dysfunction and visual disruption. Dryness, grittiness, scratchiness, discomfort, inflammation, burning, watering, ocular fatigue, pain, and decreased functional visual acuity are common symptoms of DED. Eye dysfunction drastically attenuates patients’ quality of life. Accordingly, a better understanding of the pathogenic processes that regulate the development and progression of DED is crucially important for the establishment of new and more effective DED-related treatment approaches, which would significantly improve the quality of life of DED patients. Since the process of osmoregulation, which guards the ocular surface epithelia and maintains normal vision, is affected when the osmolarity of the tears is greater than that of the epithelial cells, tear hyperosmolarity (THO) is considered an initial, important step in the development, progression, and aggravation of DED. In order to delineate the role of THO in the pathogenesis of DED, in this review article, we summarize current knowledge related to the molecular mechanisms responsible for the development of THO-induced pathological changes in the eyes of DED patients, and we briefly discuss the therapeutic potential of hypo-osmotic eye drops in DED treatment. Full article
(This article belongs to the Special Issue Mechanism of Cell Signaling during Eye Development and Diseases)
Show Figures

Figure 1

Figure 1
<p>Crucial factors contributing to the development of THO and DED. Hormones, medicaments, environmental factors, dysfunctional neural regulation of lacrimal gland secretion, poor aqueous tear flow, and excessive tear evaporation result in the development of THO. THO induces increased activation and maturation of dendritic cells, which generates a detrimental Th1 and Th17 cell-driven immune response in the eyes of DED patients. Through the production of inflammatory cytokines, Th1 and Th17 cells induce inflammation, which causes injury to the epithelial and goblet cells in the eyes of DED patients. The loss of goblet, corneal, and conjunctival epithelial cells results in excessive tear evaporation and tear film instability, which crucially contribute to the development of THO and DED.</p>
Full article ">Figure 2
<p>THO-induced changes in the phenotype and function of CECs. Apoptotic cell death is observed in THO-exposed CECs. THO induces stress in the ER and promotes mitochondrial damage by enhancing Fas- and TRAIL-dependent activation of caspase-3, capsase-8, and caspase-9, which results in apoptosis of THO-exposed CECs. Additionally, THO promotes an increased expression of E and P selectins and induces an enhanced production of inflammatory cytokines (TNF-α, IL-1β, IL-6) in CECs, which results in a massive influx of circulating immune cells in inflamed eyes of DED patients, resulting in the aggravation of ongoing inflammation.</p>
Full article ">Figure 3
<p>Detrimental immune response in the eyes of DED patients. Increased expressions of MHC proteins and co-stimulatory molecules were noticed in eye-infiltrated DCs of DED patients. DCs of DED patients have increased capacities for the production of inflammatory, pro-Th1 (IL-12), and pro-Th17 cytokines (IL-1β, IL-6, IL-12, IL-23), crucially contributing to the generation of detrimental Th1 and Th17 cell-driven immune responses. Accordingly, an increased number of IFN-γ-producing Th1, NK, and NKT cells and an increased number of IL-17- and IL-22-producing Th17 cells were observed in the eyes of DED patients. Additionally, THO promotes NETosis in eye-infiltrated neutrophils, importantly contributing to the progression of DED.</p>
Full article ">Figure 4
<p>Therapeutic potential of hypo-osmotic eye drops in DED treatment. THO induces dehydration and consequent injury of CECs. Hypo-osmotic eye drops contain a lower concentration of salt and other solutes compared to the tears on the ocular surface. Accordingly, hypo-osmotic eye drops restore the natural osmotic balance of the ocular surface, improve tear film function, and attenuate THO-induced damage of the corneal epithelial barrier.</p>
Full article ">
13 pages, 5216 KiB  
Article
Iodixanol as a New Contrast Agent for Cyanoacrylate Embolization: A Preliminary In Vivo Swine Study
by Kévin Guillen, Pierre-Olivier Comby, Alexandra Oudot, Anne-Virginie Salsac, Nicolas Falvo, Thierry Virely, Olivia Poupardin, Mélanie Guillemin, Olivier Chevallier and Romaric Loffroy
Biomedicines 2023, 11(12), 3177; https://doi.org/10.3390/biomedicines11123177 - 29 Nov 2023
Viewed by 1213
Abstract
N-butyl cyanoacrylate (NBCA) is a lipophilic, permanent embolic glue that must be opacified for fluoroscopic guidance. Empirically, lipophilic Lipiodol Ultra Fluid® (LUF) has been added to produce a single-phase physically stable mixture. Varying the dilution ratio allows control of glue polymerization kinetics. [...] Read more.
N-butyl cyanoacrylate (NBCA) is a lipophilic, permanent embolic glue that must be opacified for fluoroscopic guidance. Empirically, lipophilic Lipiodol Ultra Fluid® (LUF) has been added to produce a single-phase physically stable mixture. Varying the dilution ratio allows control of glue polymerization kinetics. LUF is far more costly than water-soluble iodinated contrast agents (ICAs). Our purpose was to evaluate whether a water-soluble nonionic iso-osmolar ICA could be used instead. We embolized both renal arteries of six swine using 1:3 NBCA–LUF or NBCA–iodixanol in 1:1, 1:3, and 1:7 ratios. We used both micro-computed tomography to assess the distality of glue penetration and indexed cast ratio and histology to assess distality, arterial obliteration, vessel-wall damage, and renal-parenchyma necrosis. Glue–LUF produced significantly greater indexed cast ratio and renal-artery ROI values and a significantly shorter cast-to-capsule distance. The injected volume was significantly greater with 1:7 iodixanol than with the other mixtures. No significant differences were found for histological evidence of artery obliteration, vessel-wall damage, or renal-parenchyma necrosis. This is the first study dealing with ICA alone as a contrast agent for cyanoacrylate embolization, compared to LUF. More research is needed to determine whether water-soluble nonionic iodinated agents can be used for human NBCA embolization given the good safety profile, availability, and low cost of ICA. Full article
(This article belongs to the Section Molecular and Translational Medicine)
Show Figures

Figure 1

Figure 1
<p>Rubbery consistency of the glue–iodixanol mixture, notably with the 1:7 ratio.</p>
Full article ">Figure 2
<p>Sites assessed for glue–ICA penetration on histological slices.</p>
Full article ">Figure 3
<p>Micro-computed tomography of an embolized swine kidney.</p>
Full article ">Figure 4
<p>Kidney embolized with 1:7 glue–iodixanol. (<b>a</b>) In situ laparoscopic view. (<b>b</b>) Appearance after excision. (<b>c</b>,<b>d</b>) Coronal ex vivo µCT images (<b>c</b>) before maximum intensity projection reconstruction, used for a more detailed assessment of fragmentation, and (<b>d</b>) post-processing segmentation (blue, renal-parenchyma segmentation; purple, cast segmentation from 1000 to 1300 HU; cyan blue, cast segmentation from 1300 to 1600 HU; and yellow, cast segmentation above 1600 HU).</p>
Full article ">Figure 5
<p>Box plots of the semi-quantitative parameters.</p>
Full article ">Figure 6
<p>Histological appearance of the glue–ICA mixture in the renal arterial tree. Top panel: Longitudinal slice, 1:3 glue–LUF on the left and 1:7 glue–iodixanol on the right. The embolized segments are seen as evenly contoured, empty spaces in the arterial lumen (Δ) mixed with fibrin and blood cells; micelles are visible on the right, with the iodixanol. Bottom panel: 1:3 glue–iodixanol. Remnants of the embolic mixture are visible in the arterial lumen as meshes or plugs (▲) of refringent material faintly stained by hemalum-eosin.</p>
Full article ">Figure 7
<p>Histological appearance of the arterial walls. The occluded arteries are dilated. Intimal endothelial-cell degeneration is visible in the left-hand panel (1:1 glue–iodixanol, arrow), fibrinoid necrosis in the middle panel (1:3 glue–iodixanol, arrow), and transmural arteritis in the right-hand panel (1:3 glue–LUF, arrow). The asterisk indicates perivascular mixed inflammatory-cell infiltration. Hemalum-eosin stain.</p>
Full article ">
17 pages, 829 KiB  
Review
Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED
by Atsushi Kawahara
Pharmaceutics 2023, 15(11), 2591; https://doi.org/10.3390/pharmaceutics15112591 - 5 Nov 2023
Cited by 4 | Viewed by 2991
Abstract
Dry eye disease (DED) is a multifactorial disorder in which tear fluid homeostasis is lost, resulting in increased tear film osmolarity and ocular surface irritation. In Asia, the short tear film breakup time-type DED, which has become a global problem in recent years, [...] Read more.
Dry eye disease (DED) is a multifactorial disorder in which tear fluid homeostasis is lost, resulting in increased tear film osmolarity and ocular surface irritation. In Asia, the short tear film breakup time-type DED, which has become a global problem in recent years, is common. While the mainstay of DED treatment in the West is the suppression of inflammation, the first goal of treatment is the stabilization of the tear film in Asia. To date, artificial tears and steroid eye drops have been the main treatment for DED. However, artificial tears require frequent administration of eye drops and thus pose adherence problems, while steroids have problems with side-effects (cataracts, increased intraocular pressure). This review evaluates the new generation therapies in Asia based on what is known about them and demonstrates that they are more effective for DED than traditional therapies such as artificial tears and steroids. Based on considerations, it is proposed that the optimal treatment for the short tear film breakup time-type DED is the initial application of mucin-secretion-enhancing eye drops (long-acting diquafosol) and oral supplements; and if additional treatment is needed, cyclosporine eye drops and the adjunctive therapies presented in this review are added. Full article
Show Figures

Figure 1

Figure 1
<p>The structure of tear film.</p>
Full article ">
16 pages, 3289 KiB  
Article
Regulation of Transporters for Organic Cations by High Glucose
by Martin Steinbüchel, Johannes Menne, Rita Schröter, Ute Neugebauer, Eberhard Schlatter and Giuliano Ciarimboli
Int. J. Mol. Sci. 2023, 24(18), 14051; https://doi.org/10.3390/ijms241814051 - 13 Sep 2023
Cited by 1 | Viewed by 1196
Abstract
Endogenous positively charged organic substances, including neurotransmitters and cationic uremic toxins, as well as exogenous organic cations such as the anti-diabetic medication metformin, serve as substrates for organic cation transporters (OCTs) and multidrug and toxin extrusion proteins (MATEs). These proteins facilitate their transport [...] Read more.
Endogenous positively charged organic substances, including neurotransmitters and cationic uremic toxins, as well as exogenous organic cations such as the anti-diabetic medication metformin, serve as substrates for organic cation transporters (OCTs) and multidrug and toxin extrusion proteins (MATEs). These proteins facilitate their transport across cell membranes. Vectorial transport through the OCT/MATE axis mediates the hepatic and renal excretion of organic cations, regulating their systemic and local concentrations. Organic cation transporters are part of the remote sensing and signaling system, whose activity can be regulated to cope with changes in the composition of extra- and intracellular fluids. Glucose, as a source of energy, can also function as a crucial signaling molecule, regulating gene expression in various organs and tissues. Its concentration in the blood may fluctuate in specific physiological and pathophysiological conditions. In this work, the regulation of the activity of organic cation transporters was measured by incubating human embryonic kidney cells stably expressing human OCT1 (hOCT1), hOCT2, or hMATE1 with high glucose concentrations (16.7 mM). Incubation with this high glucose concentration for 48 h significantly stimulated the activity of hOCT1, hOCT2, and hMATE1 by increasing their maximal velocity (Vmax), but without significantly changing their affinity for the substrates. These effects were independent of changes in osmolarity, as the addition of equimolar concentrations of mannitol did not alter transporter activity. The stimulation of transporter activity was associated with a significant increase in transporter mRNA expression. Inhibition of the mechanistic target of rapamycin (mTOR) kinase with Torin-1 suppressed the transporter stimulation induced by incubation with 16.7 mM glucose. Focusing on hOCT2, it was shown that incubation with 16.7 mM glucose increased hOCT2 protein expression in the plasma membrane. Interestingly, an apparent trend towards higher hOCT2 mRNA expression was observed in kidneys from diabetic patients, a pathology characterized by high serum glucose levels. Due to the small number of samples from diabetic patients (three), this observation must be interpreted with caution. In conclusion, incubation for 48 h with a high glucose concentration of 16.7 mM stimulated the activity and expression of organic cation transporters compared to those measured in the presence of 5.6 mM glucose. This stimulation by a diabetic environment could increase cellular uptake of the anti-diabetic drug metformin and increase renal tubular secretion of organic cations in an early stage of diabetes. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Illustrates the organic cation transport systems in human hepatocytes, while (<b>b</b>) shows the same in human renal proximal tubules. In both panels, green dots represent organic cations. In the liver (panel (<b>a</b>)), hepatocytes express OCT1, located in the sinusoidal membrane domain, facilitating the uptake of organic cations depending on their electrochemical gradient. On the other hand, MATE1 plays a major role in secreting organic cations into bile, functioning as an H<sup>+</sup>/organic cation exchanger. Moving to the kidney (panel (<b>b</b>)), proximal tubular cells contain OCT2 in the basolateral membrane domain, facilitating the uptake from the blood of organic cations based on their electrochemical gradient. For the excretion of organic cations into urine, luminally MATE1 primarily serves as an H<sup>+</sup>/organic cation exchanger. Please note that other transport systems are excluded from this figure for simplicity. Modified from [<a href="#B6-ijms-24-14051" class="html-bibr">6</a>].</p>
Full article ">Figure 2
<p>Effect of 24 h incubation with increasing glucose concentrations (5.6–16.7 mM) on the initial uptake of 1 µM ASP<sup>+</sup> in hOCT2-HEK293 cells. Before measuring ASP<sup>+</sup> uptake, the incubation solution was replaced by a Ringer-like solution (RLS). The numbers above the columns indicate the number of replicates measured in at least 3 independent experiments. The results of individual measurements are also indicated by a dot. No effect of increasing glucose concentration on ASP<sup>+</sup> uptake by hOCT2 was observed.</p>
Full article ">Figure 3
<p>Effect of 48 h incubation with increasing glucose concentrations (5.6–16.7 mM) on the initial uptake of 1 µM ASP<sup>+</sup> in hOCT2-HEK293 cells (<b>a</b>) and of 10 µM ASP<sup>+</sup> in hMATE1-HEK293 cells (<b>b</b>). Before measuring ASP<sup>+</sup> uptake, the incubation solution was replaced by RLS. The numbers above the columns indicate the number of replicates measured in at least 3 independent experiments. The results of individual measurements are also indicated by a dot. Compared to 5.6 mM glucose, all the other glucose concentrations used significantly stimulated ASP<sup>+</sup> uptake by hOCT2 (* = <span class="html-italic">p</span> &lt; 0.05, ANOVA test with Tukey’s multiple comparison). Compared with all the other glucose concentrations, ASP<sup>+</sup> uptake by hMATE1 was only significantly stimulated by 48 h incubation with 16.7 mM glucose (* = <span class="html-italic">p</span> &lt; 0.05, ANOVA test with Tukey’s multiple comparison).</p>
Full article ">Figure 4
<p>Determination of ASP<sup>+</sup> specific uptake rates of in hOCT2-HEK293 cells after 48 h incubation with 5.6 (closed squares) or 16.7 (closed circles) mM glucose. Specific ASP<sup>+</sup> initial uptake rates (dashed curves) were calculated by subtracting the “non-specific” uptake (dotted lines) evaluated as uptake in the presence of 1 mM TPA<sup>+</sup> as hOCT2 inhibitor (“non-specific” uptake, open diamonds and crosses for incubation with 5.6 or 16.7 mM glucose, respectively) from the total ASP<sup>+</sup> uptake at 37 °C (continuous solid lines, open squares and open circles for incubation with 5.6 or 16.7 mM glucose, respectively). Values are mean ± SEM of initial fluorescence increase in arbitrary units (a.u.)/s<sup>2</sup>.</p>
Full article ">Figure 5
<p>Determination of total ASP<sup>+</sup> uptake rates in hOCT1-HEK293 cells after 48 h incubation with 16.7 mM glucose (closed circles) in the presence of 10 nM (closed squares), 100 nM (open circles) and 1 µM (closed diamonds) Torin-1. Values are mean ± SEM of initial fluorescence increase in arbitrary units (a.u.)/s<sup>2</sup>.</p>
Full article ">Figure 6
<p>ASP<sup>+</sup> specific uptake rates in hOCT1- (<b>a</b>), hOCT2- (<b>b</b>) and hMATE1- (<b>c</b>) HEK293 cells after 48 h incubation with 5.6 (closed squares) or 16.7 mM glucose (closed circles) compared to those measured in the presence of 100 nM Torin-1 (open squares for measurements under 5.6 mM glucose and open circles for measurements under 16.7 mM glucose). Values are mean ± SEM of initial fluorescence increase in arbitrary units (a.u.)/s<sup>2</sup> calculated from 19–63 replicates/concentration measured in at least 3 independent experiments.</p>
Full article ">Figure 7
<p>The mRNA levels of hOCT1, hOCT2, and hMATE1 are expressed relative to mRNA GAPDH expression as 2<sup>−ΔCt</sup>, as determined by real-time PCR analysis. Transporter/GAPDH mRNA expression after 48 h incubation with 5.6 mM glucose is set to 1 (open columns). The results of individual measurements are also indicated by a dot. Transporter mRNA expression after 48 h incubation with 16.7 mM glucose (grey columns) was significantly increased (* = <span class="html-italic">p</span> &lt; 0.05, Student’s <span class="html-italic">t</span>-test) compared to that measured under 5.6 mM glucose as measured in 6 replicates in 3 independent experiments.</p>
Full article ">Figure 8
<p>Plasma membrane localization of hOCT2 after 48 h incubation with 5.6 or 16.7 mM glucose. Relative quantification of hOCT2 expression in biotinylated and total fractions from hOCT2-HEK293 cells exposed to 5.6 (open column) or 16.7 mM (grey column) glucose for 48 h. The results of individual measurements are also indicated by a dot. The hOCT2 expression in the plasma membrane after 48 h incubation with 16.7 mM glucose was significantly increased (* <span class="html-italic">p</span> &lt; 0.05, unpaired Student’s <span class="html-italic">t</span>-test) compared to that measured under 5.6 mM glucose as measured in 4 independent experiments.</p>
Full article ">Figure 9
<p>Effect of 48 h incubation with 5.6–16.7 mM glucose concentrations on initial uptake of 4 µM ASP<sup>+</sup> in MDCK cells expressing the empty vector or hOCT2. Before measuring ASP<sup>+</sup> uptake, the incubation solution was replaced by RLS. The numbers above the columns indicate the number of replicates measured in at least 3 independent experiments. The results of individual measurements are also indicated by a dot (open dots for 5.6 mM glucose, closed dots for 16.7 mM glucose). Compared to MDCK cells expressing the empty vector, hOCT2-expressing cells have a significantly higher ASP<sup>+</sup> uptake (**** <span class="html-italic">p</span> &lt; 0.0001, ANOVA test with Tukey’s multiple comparison test). Compared with 5.6 mM glucose, 16.7 mM glucose significantly stimulated ASP<sup>+</sup> uptake by hOCT2 (* <span class="html-italic">p</span> &lt; 0.05, ANOVA test with Tukey’s multiple comparison test).</p>
Full article ">Figure 10
<p>The mRNA content of hOCT2 in human kidneys is expressed relative to the mRNA expression of GAPDH as 2<sup>−ΔCt</sup>, as determined by real-time PCR analysis in samples from male (closed symbols) and female (open symbols) non-diabetic (circles) and diabetic (squares) patients. The mean hOCT2/GAPDH mRNA expression in male patients was set to 1 (interrupted line). No significant difference in hOCT2-mRNA expression was observed between the kidneys of male and female non-diabetic patients. The results obtained with samples from diabetic patients suggest a trend towards higher expression of hOCT2 in the kidneys compared to what was observed in non-diabetic patients. No statistical analysis was performed due to the small number of patients in this group. Each point represents a sample from one patient.</p>
Full article ">
26 pages, 17844 KiB  
Article
Fluid Osmolarity Modulates the Rate of Spontaneous Contraction of Lymphatic Vessels and Lymph Flow by Means of a Cooperation between TRPV and VRAC Channels
by Eleonora Solari, Cristiana Marcozzi, Daniela Negrini and Andrea Moriondo
Biology 2023, 12(7), 1039; https://doi.org/10.3390/biology12071039 - 23 Jul 2023
Cited by 1 | Viewed by 1441
Abstract
Lymphatic vessels are capable of sustaining lymph formation and propulsion via an intrinsic mechanism based on the spontaneous contraction of the lymphatic muscle in the wall of lymphatic collectors. Exposure to a hyper- or hypo-osmolar environment can deeply affect the intrinsic contraction rate [...] Read more.
Lymphatic vessels are capable of sustaining lymph formation and propulsion via an intrinsic mechanism based on the spontaneous contraction of the lymphatic muscle in the wall of lymphatic collectors. Exposure to a hyper- or hypo-osmolar environment can deeply affect the intrinsic contraction rate and therefore alter lymph flow. In this work, we aimed at defining the putative receptors underlying such a response. Functional experiments were conducted in ex vivo rat diaphragmatic specimens containing spontaneously contracting lymphatic vessels that were exposed to either hyper- or hypo-osmolar solutions. Lymphatics were challenged with blockers to TRPV4, TRPV1, and VRAC channels, known to respond to changes in osmolarity and/or cell swelling and expressed by lymphatic vessels. Results show that the normal response to a hyperosmolar environment is a steady decrease in the contraction rate and lymph flow and can be prevented by blocking TRPV1 channels with capsazepine. The response to a hyposmolar environment consists of an early phase of an increase in the contraction rate, followed by a decrease. The early phase is abolished by blocking VRACs with DCPIB, while blocking TRPV4 mainly resulted in a delay of the early response. Overall, our data suggest that the cooperation of the three channels can shape the response of lymphatic vessels in terms of contraction frequency and lymph flow, with a prominent role of TRPV1 and VRACs. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Representative image of diaphragmatic lymphatic network, highlighted by an intraperitoneal injection of FITC-dextrans, showing the organization of lymphatic vessels on the pleural side of rat diaphragm. Scale bar is 1 mm. (<b>B</b>) Representative image of a FITC-filled lymphatic vessel taken from the video recording of a spontaneously contracting tract with the indication of the 3 sites in which the diameter was measured. Scale bar is 200 μm. (<b>C</b>) STD analysis of the vessel wall of the same lymphatic tract shown in (<b>B</b>), emphasizing contracting sites (a and b), characterized by the thicker white edges highlighting the vessel wall motion, and the not-contracting one (c). (<b>D</b>) Plot of diameter profiles over time measured in a, b, and c (as indicated in panels (<b>A</b>,<b>B</b>)). Sites a and b display the typical diastolic-to-systolic contracting cycle. d<sub>D</sub>, end-diastolic diameter; d<sub>S</sub>, systolic diameter; Δd, contraction amplitude.</p>
Full article ">Figure 2
<p>(<b>A</b>) Time course of mean lymphatic intrinsic f<sub>c</sub> during <span class="html-italic">control</span><sub>308</sub> perfusion recorded either at 35 °C (hollow circles and solid line, <span class="html-italic">n</span> = 5) or 37 °C (filled circles and dashed line, <span class="html-italic">n</span> = 5), expressed as % of f<sub>c</sub> displayed at t<sub>0</sub> in <span class="html-italic">storage</span> solution at the very same bathing temperature (black and white square). At 20 min, f<sub>c</sub> was not statistically different (<span class="html-italic">p</span> = 0.748, Student’s <span class="html-italic">t</span>-test, <span class="html-italic">n</span> = 10). (<b>B</b>) Plot of intrinsic f<sub>c</sub> displayed by diaphragmatic contracting lymphatics either perfused with <span class="html-italic">control</span><sub>308</sub> (hollow circles, <span class="html-italic">n</span> = 141) or <span class="html-italic">storage</span> (hollow squares, <span class="html-italic">n</span> = 41) solutions at 35 °C.</p>
Full article ">Figure 3
<p>(<b>A</b>) Time course showing the effect of the hyperosmotic environment (<span class="html-italic">hyper</span><sub>324</sub>, filled circles) on average lymphatic intrinsic f<sub>c</sub>. Data points were fitted by a four-parameter sigmoidal equation (red solid line). Time course of isosmotic <span class="html-italic">control</span><sub>308</sub> (hollow circles and dotted line) is reported for reference. (<b>B</b>) Time course showing the effect of the hyposmotic environment (<span class="html-italic">hypo</span><sub>290</sub>, filled circles) on average lymphatic intrinsic f<sub>c</sub>. The rising period was fitted by a four-parameter sigmoidal equation (blue dashed line), whereas the following decreasing phases were fitted by two sigmoidal curves (blue solid line). Time course of isosmotic <span class="html-italic">control</span><sub>308</sub> (hollow circles and dotted line) is reported for reference.</p>
Full article ">Figure 4
<p>Time course of intrinsic f<sub>c</sub> showing that neither the vehicle (panel (<b>A</b>)), nor the nonselective TRPV1-6 (<b>B</b>), nor the selective TRPV4 or TRPV1 (<b>C</b>,<b>D</b>) channel blockers affect lymphatic intrinsic contractility under isosmotic conditions. VRAC channel blocker (<b>E</b>) also does not affect lymphatic pacemaker activity when perfused under 308 mOsm conditions.</p>
Full article ">Figure 5
<p>(<b>A</b>) Time course showing the effect of the nonselective TRPV1-6 channel blocker RuR in the 324-hypertonic solution on average f<sub>c</sub> of spontaneous contracting lymphatics. Data from RuR<sub>10</sub> (hollow circles) and RuR<sub>20</sub> (filled circles) were fitted by four-parameter sigmoidal curves (black dashed line and black solid line, respectively). Time course of the effect of the hypertonic solution alone (<span class="html-italic">hyper</span><sub>324</sub>) is reported for reference (red solid line). (<b>B</b>) Time course showing the effect of the TRPV4-selective blocker HC in the 324-hypertonic solution on average f<sub>c</sub> of spontaneous contracting lymphatics. Data from HC<sub>2.5</sub> (hollow squares) and HC<sub>5</sub> (filled squares) were fitted by four-parameter sigmoidal curves (black dashed line and black solid line, respectively). Time courses of the effect of the hypertonic solution alone (<span class="html-italic">hyper</span><sub>324</sub>, red solid line) and in presence of the vehicle (<span class="html-italic">DMSO</span><sub>0.1%</sub>, red dashed line) are reported for reference. (<b>C</b>) Time course showing the effect of the TRPV1-selective blocker caps in the 324-hypertonic solution on average f<sub>c</sub> of spontaneous contracting lymphatics. Data from caps<sub>5</sub> (hollow diamonds) were fitted by a four-parameter sigmoidal curve (black dashed line). Exposure to caps<sub>10</sub> (filled diamonds and black solid line) significantly reduced the response to the hypertonic environment. Time course of <span class="html-italic">DMSO</span><sub>0.1%</sub> (red dashed line) is reported for reference.</p>
Full article ">Figure 6
<p>(<b>A</b>) Overall effect of different channel blockers in the 324-hypertonic solution on intrinsic f<sub>c</sub>, compared to <span class="html-italic">hyper</span><sub>324</sub> (red solid bar) or <span class="html-italic">DMSO</span><sub>0.1%</sub> (red striped bar), expressed as a percentage of f<sub>c</sub> displayed at t<sub>0</sub> (100%, identified by the black dashed line). The effects of the nonselective TRPV1-6 channel blocker Ruthenium Red (10 μM white striped bar, 20 μM white solid bar), as the selective TRPV4 channel blocker HC-067047 (2.5 μM purple striped bar, 5 μM purple solid bar) or the selective TRPV1 channel blocker capsazepine (5 μM orange striped bar, 10 μM orange solid bar) were tested. RuR<sub>20</sub> significantly reduced the hyperosmolarity-induced decrease in intrinsic f<sub>c</sub>, and caps<sub>10</sub> almost abolished the lymphatic f<sub>c</sub> response to the hyperosmolar environment. All data are significantly lower than 100%, except caps<sub>10</sub>. <sup>§</sup> <span class="html-italic">p</span> &lt; 0.05 vs. RuR<sub>10</sub>, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. <span class="html-italic">DMSO</span><sub>0.1%</sub>, <sup>&amp;&amp;</sup> <span class="html-italic">p</span> &lt; 0.01 vs. caps<sub>5</sub>. (<b>B</b>) Lymphatic vessels’ end-diastolic diameter (d<sub>D</sub>) and (<b>C</b>) contraction amplitude (Δd, %) were not significantly affected by the application of different drugs (<span class="html-italic">hyper</span><sub>324,</sub> red up triangles and red solid line; <span class="html-italic">DMSO</span><sub>0.1%,</sub> red down triangles and red dashed line; RuR<sub>20,</sub> hollow circles and black dashed line; HC<sub>5,</sub> purple squares and purple dashed line; and caps<sub>10,</sub> orange diamonds and orange dashed line).</p>
Full article ">Figure 7
<p>Plot of the overall effect of different channel blockers (RuR<sub>20,</sub> hollow circles and black dashed line; HC<sub>5,</sub> purple squares and purple dashed line; and caps<sub>10,</sub> orange diamonds and orange dashed line) on <span class="html-italic">J<sub>lymph</sub></span>, expressed as a percentage of <span class="html-italic">J<sub>lymph</sub></span> at t<sub>0</sub>, compared to <span class="html-italic">hyper</span><sub>324</sub> (red up triangles and red solid line) or <span class="html-italic">DMSO</span><sub>0.1%</sub> (red down triangles and red dashed line). RuR<sub>20</sub> significantly delayed the response to the hyperosmolar solution, while caps<sub>10</sub> significantly attenuated the <span class="html-italic">J<sub>lymph</sub></span> long-term reduction, although it did not affect the time of the response.</p>
Full article ">Figure 8
<p>(<b>A</b>) Time course showing the effect of the nonselective TRPV1-6 channel blocker RuR in the 290-hypotonic solution on average f<sub>c</sub> of spontaneously contracting lymphatics. No effect was found due to RuR<sub>10</sub> (hollow circles and black dashed line), whereas RuR<sub>20</sub> (filled circles and black solid line) delayed the response to the hypotonic environment. Time course of the effect of hypotonic solution alone (<span class="html-italic">hypo</span><sub>290</sub>) is reported for reference (blue solid line). (<b>B</b>) Time course showing the effect of the TRPV4-selective blocker HC in the 290-hypotonic solution on average f<sub>c</sub> of spontaneously contracting lymphatics. Early response in HC<sub>5</sub> (hollow squares and black dashed line) was similar to <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue dashed line), whereas exposure to HC<sub>10</sub> (filled squares and black solid line) smoothed the shape of the early peak. (<b>C</b>) Time course showing the effect of the TRPV1-selective blocker caps in the 290-hypotonic solution on average f<sub>c</sub> of spontaneously contracting lymphatics. No effects were found in the early increasing phase both in caps<sub>5</sub> (hollow diamonds and black dashed line) and caps<sub>10</sub> (filled diamonds and black solid line). At t<sub>15,</sub> lymphatics challenged with caps<sub>10</sub> displayed a f<sub>c</sub> significantly higher than <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue dashed line).</p>
Full article ">Figure 9
<p>(<b>A</b>) Overall effect of different channel blockers in the 290-hypotonic solution, compared to <span class="html-italic">hypo</span><sub>290</sub> (blue solid bars) or <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue striped bars), on early and late response of intrinsic f<sub>c</sub> (expressed as a percentage of f<sub>c</sub> displayed at t<sub>0</sub>). The effects of the nonselective TRPV1-6 channel blocker Ruthenium Red (10 μM white striped bars, 20 μM white solid bars), the selective TRPV4 channel blocker HC-067047 (2.5 μM purple narrow striped bars, 5 μM purple wide striped bars, and 10 µM purple solid bars), or the selective TRPV1 channel blocker capsazepine (5 μM orange striped bars, 10 μM orange solid bars) were tested. None of the channel blockers, at any concentration used, affected the early f<sub>c</sub> peak (mean value of f<sub>c</sub> peak for each tested vessel). caps<sub>10</sub> induced a significant effect on the late plateau, with f<sub>c</sub> being higher than <span class="html-italic">DMSO</span><sub>0.1%</sub> after 15 min of perfusion. <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. <span class="html-italic">DMSO</span><sub>0.1%</sub>. For all tested conditions, early f<sub>c</sub> peaks were significantly higher than 100%; late endpoints were significantly lower than 100% except caps<sub>10</sub>. (<b>B</b>) Effect of different channel blockers in the 290-hypotonic buffer on the time interval to peak (mean time required by each vessel to reach its own f<sub>c</sub> peak). HC displayed a minor, but not significant, time delay in the response to hyposmolarity as the time to peak became longer.</p>
Full article ">Figure 10
<p>(<b>A</b>) Lymphatic vessels’ end-diastolic diameter and (<b>B</b>) contraction amplitude (Δd %) were not affected by the different drugs used (<span class="html-italic">hypo</span><sub>290,</sub> blue up triangles and blue solid lines; <span class="html-italic">DMSO</span><sub>0.1%,</sub> blue down triangles and blue dashed lines; RuR<sub>20,</sub> hollow circles and black dashed lines; HC<sub>10,</sub> purple squares and purple dashed lines; and caps<sub>10,</sub> orange diamonds and orange dashed lines). (<b>C</b>) Plot of the overall effect of different channel blockers on <span class="html-italic">J<sub>lymph</sub></span> (RuR<sub>20,</sub> hollow circles and black dashed line; HC<sub>10,</sub> purple squares and purple dashed line; and caps<sub>10,</sub> orange diamonds and orange dashed line) expressed as a percentage of <span class="html-italic">J<sub>lymph</sub></span> at t<sub>0</sub>, compared to <span class="html-italic">hypo</span><sub>290</sub> (blue up triangles and blue solid line) or <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue down triangles and blue dashed line). caps<sub>10</sub> significantly delayed the late response to the hypotonic environment, whereas HC<sub>10</sub> significantly attenuated the <span class="html-italic">J<sub>lymph</sub></span> long-term reduction.</p>
Full article ">Figure 11
<p>(<b>A</b>) Relative gene expression of VRACs in not-contracting (filled circles) and spontaneously contracting (hollow circles) diaphragmatic lymphatics, compared to the respective expression in dorsal root ganglions (DRGs; grey squares) used as positive controls. VRACs were similarly expressed in both contracting and not-contracting vessels; <span class="html-italic">n</span> = 4 animals for all genes tested. (<b>B</b>) Time course showing the effect of DCPIB (5 µM), the VRAC-selective inhibitor, in the 290-hypotonic solution on average f<sub>c</sub> of spontaneous contracting lymphatics. DCPIB<sub>5</sub> (hollow hexagons and black dashed line) completely abolished the early f<sub>c</sub> response. <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue dashed line) is reported for reference. (<b>C</b>) Early and late effects of DCPIB<sub>5</sub> (green solid bars) on intrinsic f<sub>c</sub> (expressed as a percentage of f<sub>c</sub> displayed at t<sub>0</sub>) compared to <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue striped bars), measured at the same interval as the <span class="html-italic">DMSO</span><sub>0.1%</sub> peak occurred. <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. <span class="html-italic">DMSO</span><sub>0.1%</sub>.</p>
Full article ">Figure 12
<p>(<b>A</b>) Lymphatic vessels’ end-diastolic diameter and (<b>B</b>) contraction amplitude (Δd %) were not affected by DCPIB<sub>5</sub> (green hexagons and green dashed lines). <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue down triangles and blue dashed lines) is reported for reference. (<b>C</b>) Plot of the overall effect of DCPIB<sub>5</sub> on <span class="html-italic">J<sub>lymph</sub></span> (green hexagons and green dashed line) expressed as a percentage of <span class="html-italic">J<sub>lymph</sub></span> at t<sub>0</sub>, compared to <span class="html-italic">DMSO</span><sub>0.1%</sub> (blue down triangles and blue dashed line). DCPIB<sub>5</sub> completely abolished the early <span class="html-italic">J<sub>lymph</sub></span> peak induced by the hypotonic environment.</p>
Full article ">Figure 13
<p>Plot of intrinsic f<sub>c</sub> modifications (z-axis—expressed as a percentage of f<sub>c</sub> at t<sub>0</sub>) as a function of elapsed time (x-axis) and TRPV1 (capsazepine, panels (<b>A</b>,<b>B</b>)) or TRPV4 (HC-067047, panels (<b>C</b>,<b>D</b>)) channel blockers’ concentration (y-axis), combined with different fluid osmolarities (324 mOsm for panels (<b>A</b>,<b>C</b>) and 290 mOsm for panels (<b>B</b>,<b>D</b>)).</p>
Full article ">
13 pages, 1344 KiB  
Article
Short-Term Thermal Stress Affects Immune Cell Features in the Sea Urchin Paracentrotus lividus
by Carola Murano, Alessandra Gallo, Aurora Nocerino, Alberto Macina, Stefano Cecchini Gualandi and Raffaele Boni
Animals 2023, 13(12), 1954; https://doi.org/10.3390/ani13121954 - 11 Jun 2023
Cited by 3 | Viewed by 1696
Abstract
Due to global warming, animals are experiencing heat stress (HS), affecting many organic functions and species’ survival. In this line, some characteristics of immune cells in sea urchins subjected to short-term HS were evaluated. Paracentrotus lividus adult females were randomly divided into three [...] Read more.
Due to global warming, animals are experiencing heat stress (HS), affecting many organic functions and species’ survival. In this line, some characteristics of immune cells in sea urchins subjected to short-term HS were evaluated. Paracentrotus lividus adult females were randomly divided into three groups and housed in tanks at 17 °C. In two of these tanks, the temperatures were gradually increased up to 23 and 28 °C. Celomatic fluid was collected after 3 and 7 days. The coelomocytes were morphologically typed and evaluated for their mitochondrial membrane potential (MMP), lipoperoxidation extent (LPO), and hydrogen peroxide content (H2O2). Respiratory burst was induced by treatment with phorbol 12-myristate 13-acetate (PMA). HS caused a significant change in the coelomocytes’ type distribution. MMP increased in the 23 °C-group and decreased in the 28 °C-group at both 3 and 7 days. LPO only increased in the 28 °C-group at 7 days. H2O2 progressively decreased together with the temperature increase. Respiratory burst was detected in all groups, but it was higher in the 17 °C group. In conclusion, the increase in temperature above the comfort zone for this animal species affects their immune cells with possible impairment of their functions. Full article
(This article belongs to the Section Animal Physiology)
Show Figures

Figure 1

Figure 1
<p>Immune cell type distribution (%, mean ± SD) in sea urchins after 3 (<b>A</b>) and 7 (<b>B</b>) days of exposure at 17, 23, and 28 °C. (P) Phagocytes; (R) red amoebocytes; (W) white amoebocytes; (V) and vibratile cells. Different letters (a, b, and c) mark statistically significant (<span class="html-italic">p</span> &lt; 0.05) differences within the cell types and between the experimental groups.</p>
Full article ">Figure 2
<p>Mean (±SD) values of mitochondrial membrane potential (<b>A</b>), lipid peroxidation (<b>B</b>), and hydrogen peroxide content (<b>C</b>) in the coelomocytes of the sea urchin specimens exposed to 23 and 28 °C and to a thermal comfort temperature (17 °C) for 3 and 7 days. Statistically significant (<span class="html-italic">p</span> &lt; 0.05) differences within each time of exposure are marked with a, b, and c.</p>
Full article ">Figure 3
<p>Mean values of mitochondrial membrane potential (<b>A</b>) and hydrogen peroxide content (<b>B</b>) in the coelomocytes of sea urchin specimens (<span class="html-italic">n</span> = 6) exposed to 23 and 28 °C and to a thermal comfort temperature (17 °C) for 3 days and treated with 10 µg PMA mL<sup>−1</sup>. Time 0 = 1 min before PMA treatment; time 1, 15 and 30 = 1, 15, and 30 min after PMA treatment, respectively. Statistically significant (<span class="html-italic">p</span> &lt; 0.05) differences with values at 28 °C are marked with a and b.</p>
Full article ">
15 pages, 2679 KiB  
Article
Preparation and Characterisation of a Cyclodextrin-Complexed Mānuka Honey Microemulsion for Eyelid Application
by Ilva D. Rupenthal, Priyanka Agarwal, Benedict Uy, Jaeun Kim, Angela A. Cunningham, Ali Seyfoddin, Simon Swift and Jennifer P. Craig
Pharmaceutics 2022, 14(7), 1493; https://doi.org/10.3390/pharmaceutics14071493 - 19 Jul 2022
Cited by 2 | Viewed by 2068
Abstract
Honey has been widely purported as a natural remedy due to its antimicrobial and anti-inflammatory effects. In recent years, several studies have suggested that the considerably high methylglyoxal (MGO) concentration in Mānuka honey (MH) makes it particularly effective to manage bacterial overload, such [...] Read more.
Honey has been widely purported as a natural remedy due to its antimicrobial and anti-inflammatory effects. In recent years, several studies have suggested that the considerably high methylglyoxal (MGO) concentration in Mānuka honey (MH) makes it particularly effective to manage bacterial overload, such as that observed in blepharitis. However, the poor solubility, high viscosity, and osmolarity of aqueous honey solutions, especially at the high MGO concentrations studied in the literature, render the formulation of an acceptable dosage form for topical application to the eyelids challenging. Here, the antibacterial properties of raw MH and alpha-cyclodextrin (α-CD)-complexed MH were evaluated at relatively low MGO concentrations, and a liquid crystalline-forming microemulsion containing α-CD-complexed MH was formulated. After determining pH and osmolarity, ocular tolerability was assessed using human primary corneal epithelial cells and chorioallantoic membranes, while the antibacterial efficacy was further evaluated in vitro. The α-CD–MH complex had significantly greater antibacterial activity against Staphylococcus aureus than either constituent alone, which was evident even when formulated as a microemulsion. Moreover, the final formulation had a physiologically acceptable pH and osmolarity for eyelid application and was well-tolerated when diluted 1:10 with artificial tear fluid, as expected to be the case after accidental exposure to the ocular surface in the clinical setting. Thus, a safe and efficient MH dosage form was developed for topical application to the eyelids, which can potentially be used to support optimal eyelid health in the management of blepharitis. Full article
(This article belongs to the Special Issue Cyclodextrins and Their Inclusion Complexes for Pharmaceutical Uses)
Show Figures

Figure 1

Figure 1
<p>Relative cell viability (%) of <span class="html-italic">S. aureus</span> on exposure to (<b>A</b>) 50, (<b>B</b>) 75, and (<b>C</b>) 100 mg/kg MGO normalised to the values observed with media. Box plots showing the range with the bar as the mean (<span class="html-italic">n</span> = 3). A bactericidal effect, defined as no CFUs being observed in plated samples after overnight incubation, is denoted by *.</p>
Full article ">Figure 2
<p>Relative cell viability of HCECs upon exposure to MH, CYP, and α-CD for (<b>A</b>) 15 min and (<b>B</b>) 1 h (mean + SD; <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 3
<p>Formulation characteristics of (<b>A</b>) blank ME formulation and (<b>B</b>) ME formulated with 100 mg/kg MGO CYP (clockwise from left: visual appearance, skin spreadability, and scanning electron micrograph (scale bar = 5 µm)).</p>
Full article ">Figure 4
<p>Zone of inhibition of bacterial growth with fusidic acid (positive control), 100 MGO CYP ME, and α-CD (≡100 MGO CYP) ME.</p>
Full article ">Figure 5
<p>Relative cell viability (%) of HCECs on exposure to various dilutions of the formulation excipients and the final ME for (<b>A</b>) 15 min and (<b>B</b>) 1 h (mean ± SD; <span class="html-italic">n</span> = 3).</p>
Full article ">Figure 6
<p>(<b>A</b>) Cumulative score and irritation potential with individual data points with bars representing the mean (<span class="html-italic">n</span> = 3) and (<b>B</b>) representative HET-CAM images after 5 min of exposure to the excipients and final ME formulation.</p>
Full article ">
12 pages, 2744 KiB  
Article
TRPV1-Mediated Sensing of Sodium and Osmotic Pressure in POMC Neurons in the Arcuate Nucleus of the Hypothalamus
by Boyang Zhang, Kazuomi Kario, Toshihiko Yada and Masanori Nakata
Nutrients 2022, 14(13), 2600; https://doi.org/10.3390/nu14132600 - 23 Jun 2022
Cited by 4 | Viewed by 2606
Abstract
The central melanocortin system conducted by anorexigenic pro-opiomelanocortin (POMC) neurons and orexigenic agouti-related peptide (AgRP) neurons in the arcuate nucleus of the hypothalamus (ARC) not only regulates feeding behavior but also blood pressure. Excessive salt intake raises the Na+ concentration ([Na+ [...] Read more.
The central melanocortin system conducted by anorexigenic pro-opiomelanocortin (POMC) neurons and orexigenic agouti-related peptide (AgRP) neurons in the arcuate nucleus of the hypothalamus (ARC) not only regulates feeding behavior but also blood pressure. Excessive salt intake raises the Na+ concentration ([Na+]) in the cerebrospinal fluid (CSF) and worsens hypertension. The blood–brain barrier is immature in the ARC. Therefore, both AgRP and POMC neurons in the ARC have easy access to the electrolytes in the blood and can sense changes in their concentrations. However, the sensitivity of AgRP and POMC neurons to Na+ remains unclear. This study aimed to explore how the changes in the extracellular Na+ concentration ([Na+]) influence these neurons by measuring the cytosolic Ca2+ concentration ([Ca2+]i) in the single neurons isolated from the ARC that were subsequently immunocytochemically identified as AgRP or POMC neurons. Both AgRP and POMC neurons responded to increases in both [Na+] and osmolarity in C57BL/6 mice. In contrast, in transient receptor potential vanilloid 1 (TRPV1) knockout (KO) mice, POMC neurons failed to respond to increases in both [Na+] and osmolarity, while they responded to high glucose and angiotensin II levels with increases in [Ca2+]i. Moreover, in KO mice fed a high-salt diet, the expression of POMC was lower than that in wild-type mice. These results demonstrate that changes in [Na+] and osmolarity are sensed by the ARC POMC neurons via the TRPV1-dependent mechanism. Full article
Show Figures

Figure 1

Figure 1
<p>Increased extracellular [Na<sup>+</sup>] increased [Ca<sup>2+</sup>]<sub>i</sub> in single AgRP and POMC neurons isolated from ARC of wild-type mice.(<b>A</b>,<b>B</b>) Left panel: Typical examples of [Ca<sup>2+</sup>]<sub>i</sub> responses to [Na<sup>+</sup>] increase and 10<sup>−5</sup> M glutamate (GA) in single ARC neurons. Right panel: The single ARC neurons were subsequently shown to be IR to AgRP (<b>A</b>) and POMC (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses to increased extracellular [Na<sup>+</sup>] (Δratio) in AgRP and POMC neurons. Data are presented as mean ± SEM.</p>
Full article ">Figure 2
<p>Increased extracellular [Na<sup>+</sup>] failed to substantially increase [Ca<sup>2+</sup>]<sub>i</sub> in single POMC neurons in ARC from TRPV1 KO mice. (<b>A</b>,<b>B</b>) Typical examples of [Ca<sup>2+</sup>]<sub>i</sub> responses to [Na<sup>+</sup>] increase and 10<sup>−5</sup> M glutamate (GA) in single ARC POMC neuron from wild-type mice (<b>A</b>) and TRPV1 KO mice (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses to increased extracellular [Na<sup>+</sup>] (Δratio) in POMC neurons. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">Figure 3
<p>Increased extracellular [Na<sup>+</sup>] increased [Ca<sup>2+</sup>]<sub>i</sub> in single AgRP neurons from TRPV1 KO mice. (<b>A</b>,<b>B</b>) Typical example of [Ca<sup>2+</sup>]<sub>i</sub> responses to [Na<sup>+</sup>] increase and 10<sup>−5</sup> M glutamate (GA) in AgRP neurons from wild-type mice (<b>A</b>) and TRPV1 KO mice (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses to increased extracellular [Na<sup>+</sup>] (Δratio) in AgRP neurons. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">Figure 4
<p>Mannitol increased [Ca<sup>2+</sup>]<sub>i</sub> in single POMC neurons in ARC. (<b>A</b>,<b>B</b>) Typical example of [Ca<sup>2+</sup>]<sub>i</sub> responses to mannitol and 10<sup>−5</sup> M glutamate (GA) in POMC neurons isolated from wild-type (WT) mice (<b>A</b>) and TRPV1 KO mice (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses to mannitol (Δratio) in POMC neurons. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">Figure 5
<p>Glucose increased [Ca<sup>2+</sup>]<sub>i</sub> in single POMC neurons. (<b>A</b>,<b>B</b>) Glucose (8.3 mM) increased [Ca<sup>2+</sup>]<sub>i</sub> in POMC neurons from wild-type (WT) mice (<b>A</b>) and TRPV1 KO mice (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses (Δratio) in POMC neurons. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">Figure 6
<p>Angiotensin II increased [Ca<sup>2+</sup>]<sub>i</sub> in single POMC neurons. (<b>A</b>,<b>B</b>) Angiotensin II increased [Ca<sup>2+</sup>]<sub>i</sub> in single POMC neurons from wild-type (WT) mice (<b>A</b>) and TRPV1 KO mice (<b>B</b>). Scale bar is 20 μm. (<b>C</b>) Average amplitude of [Ca<sup>2+</sup>]<sub>i</sub> responses to angiotensin II (Δratio) in POMC neurons. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">Figure 7
<p>Relative mRNA expression (fold changes) in AgRP and POMC in ARC after 24 h of being fed a high-salt diet. WT mice and TRPV1 KO mice were fed either a low-salt diet (0.3% NaCl) or high-salt diet (8% NaCl) for 24 h. The expression of POMC in ARC was significantly decreased after 24 h of a high-salt diet in TRPV1 KO mice. □, WT mice; ■, TRPV1 KO mice. N = 6 for each group. Data are presented as mean ± SEM. WT vs. KO determined by one-way ANOVA followed by the Bonferroni test.</p>
Full article ">
12 pages, 10685 KiB  
Article
An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
by Josefine C. Freiberg, Anne Hedengran, Steffen Heegaard, Goran Petrovski, Jette Jacobsen, Barbara Cvenkel and Miriam Kolko
J. Clin. Med. 2022, 11(11), 3137; https://doi.org/10.3390/jcm11113137 - 31 May 2022
Cited by 6 | Viewed by 4404
Abstract
Purpose: To examine the physicochemical properties of five preservative-free (PF) 0.005% latanoprost ophthalmic products; Monoprost®, Latanest®, Gaap Ofteno®, Xalmono®, and Xaloptic® Free. Furthermore, the study investigated the mucin production and cell survival of primary [...] Read more.
Purpose: To examine the physicochemical properties of five preservative-free (PF) 0.005% latanoprost ophthalmic products; Monoprost®, Latanest®, Gaap Ofteno®, Xalmono®, and Xaloptic® Free. Furthermore, the study investigated the mucin production and cell survival of primary cultured human conjunctival goblet cells when treated with PF eye drops. Method: The pH value, osmolality, and surface tension were examined. Cell survival was analyzed using lactate dehydrogenase and tetrazolium dye colorimetric assays. Mucin production was analyzed with immunohistochemical staining. Results: Monoprost® (pH value 6.84 ± 0.032) had a pH value closest to the pH value of tear fluid (pH value 7.4–7.6), whereas Gaap Ofteno® (pH value 6.34 ± 0.004) and Latanest® (pH value 6.33 ± 0.003) had the lowest pH values. Gaap Ofteno® (325.9 ± 2.9 mosmol/kg) showed iso-osmolar probabilities, whereas the other products were hypo-osmolar. Gaap Ofteno® (60.31 ± 0.35 mN/m) had a higher surface tension compared to the tear fluid (40 to 46 mN/m), as described in the literature. No significant differences in goblet cell survival or mucin release were observed between the treatments and control. Conclusion: Significant differences in pH value, osmolality, and surface tension were observed. However, this did not affect the viability of the goblet cells or the release of mucin. Clinical studies are required to evaluate the long-term effects of use on efficacy and safety. Full article
(This article belongs to the Special Issue Going for Gaps in Glaucoma)
Show Figures

Figure 1

Figure 1
<p>The pH value characterization of preservative-free 0.005% latanoprost products Monoprost<sup>®</sup>, Latanest<sup>®</sup>, Gaap Ofteno<sup>®</sup>, Xalmono<sup>®</sup>, and Xaloptic<sup>®</sup> Free: (<b>a</b>) pH value of the undiluted eye drops; (<b>b</b>) pH value of the diluted eye drops (1:7, <span class="html-italic">v</span>/<span class="html-italic">v</span>). Values are listed as mean ± SD, and <span class="html-italic">n</span> = 3. A one-way ANOVA with a Tukey multiple-comparison test (<span class="html-italic">p</span> = 0.05) was performed. ns = not significant, with <span class="html-italic">p</span> ≥ 0.05, *** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 2
<p>Osmolality characterization of preservative-free 0.005% latanoprost eye drops Monoprost<sup>®</sup>, Latanest<sup>®</sup>, Gaap Ofteno<sup>®</sup>, Xalmono<sup>®</sup> and Xaloptic<sup>®</sup> Free: (<b>a</b>) osmolality of the undiluted eye drops; (<b>b</b>) osmolality of the diluted eye drops (1:7, <span class="html-italic">v</span>/<span class="html-italic">v</span>). Values are listed as mean ± SD, and <span class="html-italic">n</span> = 3. A one-way ANOVA with a Tukey multiple-comparison test (<span class="html-italic">p</span> = 0.05) was performed. ns = not significant with <span class="html-italic">p</span> ≥ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 3
<p>Surface tension characterization of preservative-free 0.005% latanoprost products; Monoprost<sup>®</sup>, Latanest<sup>®</sup>, Gaap Ofteno<sup>®</sup>, Xalmono<sup>®</sup> and Xaloptic<sup>®</sup> Free. Values are listed as mean ± SD, <span class="html-italic">n</span> = 3. A one-way ANOVA with a Tukey multiple-comparison test (<span class="html-italic">p</span> = 0.05) were performed. ns = not significant with <span class="html-italic">p</span> ≥ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001.</p>
Full article ">Figure 4
<p>Mean cell survival analysis of human conjunctival goblet cells in % ± SD, relative to control, after 30 min of treatment with preservative-free 0.005% latanoprost eye drops. (<b>a</b>) Cell survival, examined with the LDH assay; (<b>b</b>) cell survival, examined with the MTT assay. Goblet cells were treated with diluted (1:7, <span class="html-italic">v</span>/<span class="html-italic">v</span>) preservative-free 0.005% latanoprost products: Monoprost<sup>®</sup>, Latanest<sup>®</sup>, Gaap Ofteno<sup>®</sup>, Xalmono<sup>®</sup>, and Xaloptic<sup>®</sup> Free. A one-way ANOVA with a Tukey multiple-comparison test was performed (<span class="html-italic">p</span> = 0.05), <span class="html-italic">n</span> ≥ 4; ns = not significant; <span class="html-italic">p</span> ≥ 0.05.</p>
Full article ">Figure 5
<p>Immunohistochemical staining of human goblet cells, visualizing the cytoskeleton (column 1: Cytokeratin-7, green), mucin (column 2: mucin, red), the nucleus (column 3: DAPI, blue), and merged stainings (column 4: cytokeratin-7 (green), mucin (red) and DAPI (blue)). Cells were treated with diluted (1:7, <span class="html-italic">v</span>/<span class="html-italic">v</span>) 0.005% latanoprost preservative-free products. (<b>A</b>): RPMI media, (<b>B</b>): Monoprost <sup>®</sup>, (<b>C</b>): Latanest<sup>®</sup>, (<b>D</b>): Gaap Ofteno<sup>®</sup>, (<b>E</b>): Xalmono<sup>®</sup>, and (<b>F</b>): Xaloptic<sup>®</sup> Free. <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 5 Cont.
<p>Immunohistochemical staining of human goblet cells, visualizing the cytoskeleton (column 1: Cytokeratin-7, green), mucin (column 2: mucin, red), the nucleus (column 3: DAPI, blue), and merged stainings (column 4: cytokeratin-7 (green), mucin (red) and DAPI (blue)). Cells were treated with diluted (1:7, <span class="html-italic">v</span>/<span class="html-italic">v</span>) 0.005% latanoprost preservative-free products. (<b>A</b>): RPMI media, (<b>B</b>): Monoprost <sup>®</sup>, (<b>C</b>): Latanest<sup>®</sup>, (<b>D</b>): Gaap Ofteno<sup>®</sup>, (<b>E</b>): Xalmono<sup>®</sup>, and (<b>F</b>): Xaloptic<sup>®</sup> Free. <span class="html-italic">n</span> = 3.</p>
Full article ">
11 pages, 1761 KiB  
Article
Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction
by Chih-Kang Hsu, Meng-Wei Hsieh, Hsu-Chieh Chang, Yi-Hao Chen and Ke-Hung Chien
J. Pers. Med. 2022, 12(5), 802; https://doi.org/10.3390/jpm12050802 - 16 May 2022
Cited by 2 | Viewed by 2181
Abstract
There is a high incidence of ocular surface disease (OSD) in thyroid-associated orbitopathy (TAO) patients as a result of incomplete eyelid closure and chronic inflammatory eyelid status. This study was performed to evaluate the efficacy of a lateral tarsoconjunctival flap (LTF) in improving [...] Read more.
There is a high incidence of ocular surface disease (OSD) in thyroid-associated orbitopathy (TAO) patients as a result of incomplete eyelid closure and chronic inflammatory eyelid status. This study was performed to evaluate the efficacy of a lateral tarsoconjunctival flap (LTF) in improving OSD in TAO patients from the perspective of correcting eyelid closures. As a study design, TAO patients were enrolled in this study to evaluate OSD perioperatively before they were scheduled for LTF surgery. Additional lid surgery was also recorded. The outcome was evaluated with perioperative OSD measurements and tear inflammatory mediators at baseline and one month and three months postoperatively. As a result, 42 patients (5 male, 37 female) underwent LTF surgery, and 13 patients received medial pretarsal support with collagen grafts. Eleven patients underwent blepharotomy, and 6 patients received Botox injections for upper lid retraction. The mean age of the participants was 46.4 years old, and the mean follow-up period was 10.6 months. Their clinical activity score (CAS) at the time of the operation was 2.1. Dry eye parameters, such as ocular surface disease index, tear breakup time, Schirmer’s I test score, and meibomian gland dropout were all significantly improved 3 months postoperatively. Tear osmolarity and inflammatory mediators in tear fluid, such as IL-6, IL-8, IL-18 and MCP-1, were also significantly improved after the procedures. After the surgery, all complications were mild and temporary. As a conclusion, LTF could provide TAO patients with both lid retraction correction and improvement of ocular surface disorders. Dry eye parameters significantly improved 3 months postoperatively. This method can serve as an alternative treatment option for lid correction in TAO patients. Full article
(This article belongs to the Special Issue Good Clinical Practice in Plastic Surgery)
Show Figures

Figure 1

Figure 1
<p>Surgical procedures illustration of lateral tarsoconjunctival flap (LTF). Briefly, an area measuring 4 mm (vertical length) × 4–6 mm (horizontal length) from the lid margin was marked over the tarsal conjunctiva to create a partial tarsal graft after the upper lid was everted (<b>A</b>). Then, the lateral 4–6 mm aspect of the lower lid margin was denuded posterior to the grey line with 15-blade or Westcott scissors (<b>B</b>). Finally, one or two interrupted, 5-0 Vicryl sutures were placed at the inferior edge of the upper eyelid flap and the denuded lower eyelid margin to create the LTF (<b>C</b>,<b>D</b>).</p>
Full article ">Figure 2
<p>External ocular photos showed lower lid retraction with 2–3 mm scleral show and entropion (<b>A</b>). Three months postoperatively, entropion with retraction was corrected with LTF which was barely seen in the lateral canthus (pointed by arrowhead) (<b>B</b>). Diffuse superficial punctate kearatopathy was seen over middle to inferior third of the cornea surface before LTF surgery (<b>C</b>). Three months postoperatively, the cornea surface was recovered without apparent corneal damage noted (<b>D</b>) (Different patients between (<b>A</b>,<b>B</b>) and (<b>C</b>,<b>D</b>)).</p>
Full article ">Figure 3
<p>Blinking efficiency improved after the LTF procedure. Before the procedure, there were significantly Meibomian gland drop-outs both in the upper and lower lids with several partial blinks (incomplete blinking) (<b>A</b>). Three months after the procedure (the LTF was marked by the arrow), blinking efficiency was significantly improved with fewer meibomian gland drop-outs and no incomplete blinking (<b>B</b>).</p>
Full article ">
11 pages, 618 KiB  
Article
Effect of Vitamin C and Protein Supplementation on Plasma Nitrate and Nitrite Response following Consumption of Beetroot Juice
by Gary D. Miller, Beverly A. Nesbit, Daniel B. Kim-Shapiro, Swati Basu and Michael J. Berry
Nutrients 2022, 14(9), 1880; https://doi.org/10.3390/nu14091880 - 29 Apr 2022
Cited by 5 | Viewed by 2718
Abstract
Beetroot juice is a food high in nitrate and is associated with cardiometabolic health benefits and enhanced exercise performance through the production of nitric oxide in the nitrate–nitrite–nitric oxide pathway. Since various food components influence this pathway, the aim of this trial was [...] Read more.
Beetroot juice is a food high in nitrate and is associated with cardiometabolic health benefits and enhanced exercise performance through the production of nitric oxide in the nitrate–nitrite–nitric oxide pathway. Since various food components influence this pathway, the aim of this trial was to study the effect of beetroot juice alone and in conjunction with vitamin C or protein on the acute response to plasma nitrate and nitrite levels in healthy middle- to older-aged adults. In this cross-over trial, each participant received, in a randomized order, a single dose of Beet It Sport® alone; Beet It Sport®, plus a 200 mg vitamin C supplement; and Beet It Sport® plus 15 g of whey protein. Plasma levels of nitrate and nitrite were determined prior to and at 1 and 3 h after intervention. Log plasma nitrate and nitrite was calculated to obtain data that were normally distributed, and these data were analyzed using two-way within-factors ANOVA, with time and treatment as the independent factors. There were no statistically significant differences for log plasma nitrate (p = 0.308) or log plasma nitrite (p = 0.391) values across treatments. Log plasma nitrate increased significantly from pre-consumption levels after 1 h (p < 0.001) and 3 h (p < 0.001), but plasma nitrate was lower at 3 h than 1 h (p < 0.001). Log plasma nitrite increased from pre to 1 h (p < 0.001) and 3 h (p < 0.001) with log values at 3 h higher than at 1 h (p = 0.003). In this cohort, we observed no differences in log plasma nitrate and nitrite at 1 h and 3 h after co-ingesting beetroot juice with vitamin C or a whey protein supplement compared to beetroot juice alone. Further research needs to be undertaken to expand the blood-sampling time-frame and to examine factors that may influence the kinetics of the plasma nitrate to nitrite efficacy, such as differences in fluid volume and osmolarity between treatments employed. Full article
(This article belongs to the Section Micronutrients and Human Health)
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>–<b>c</b>). Individual responses in plasma nitrite following consumption of beetroot juice alone (<b>a</b>), with vitamin C (<b>b</b>) and with protein (<b>c</b>). The treatment mean is depicted in the large dashed red line and the black dotted line at 0.5 mM line shows the level marking responders vs. non-responders.</p>
Full article ">Figure 1 Cont.
<p>(<b>a</b>–<b>c</b>). Individual responses in plasma nitrite following consumption of beetroot juice alone (<b>a</b>), with vitamin C (<b>b</b>) and with protein (<b>c</b>). The treatment mean is depicted in the large dashed red line and the black dotted line at 0.5 mM line shows the level marking responders vs. non-responders.</p>
Full article ">
12 pages, 2881 KiB  
Article
Three-Dimensional Kidney-on-a-Chip Assessment of Contrast-Induced Kidney Injury: Osmolality and Viscosity
by Kipyo Kim, Beomgyun Jeong, Yun-Mi Lee, Hyung-Eun Son, Ji-Young Ryu, Seokwoo Park, Jong Cheol Jeong, Ho Jun Chin and Sejoong Kim
Micromachines 2022, 13(5), 688; https://doi.org/10.3390/mi13050688 - 28 Apr 2022
Cited by 9 | Viewed by 2887
Abstract
Increased viscosity of concentrated contrast media (CM) in the renal tubules can perturb renal hemodynamics and have a detrimental effect on tubular epithelial cells. However, the effects of viscosity on contrast-induced nephropathy (CIN) remain poorly understood. Conventional in vitro culture studies do not [...] Read more.
Increased viscosity of concentrated contrast media (CM) in the renal tubules can perturb renal hemodynamics and have a detrimental effect on tubular epithelial cells. However, the effects of viscosity on contrast-induced nephropathy (CIN) remain poorly understood. Conventional in vitro culture studies do not reflect the rheological properties of CM. Therefore, we investigated the effects of CM viscosity on renal tubules using a kidney-on-a-chip and two different types of CM. Renal proximal tubule epithelial cells (RPTEC) were cultured in a three-dimensional microfluidic culture platform under bidirectional fluid shear stress. We treated the RPTEC with two types of CM: low- (LOCM, iopromide) and iso-osmolar contrast media (IOCM, iodixanol). Renal tubular cell injury induced by LOCM and IOCM was examined under different iodine concentrations (50–250 mgI/mL) and shear-stress conditions. LOCM showed a significant dose-dependent cytotoxic effect, which was significantly higher than that of IOCM under static and low-to-moderate shear stress conditions. However, high shear-stress resulted in reduced cell viability in IOCM; no difference between IOCM and LOCM was found under high shear-stress conditions. The cytotoxic effects were pronounced at a mean shear stress of 1 dyn/cm2 or higher. The high viscosity of IOCM slowed the fluid flow rate and augmented fluid shear-stress. We suggest an alternative in vitro model of CIN using the three-dimensional kidney-on-a-chip. Our results indicate a vital role of viscosity-induced nephrotoxicity under high shear-stress conditions, contrary to the findings of conventional in vitro studies. Full article
(This article belongs to the Special Issue Feature Papers of Micromachines in Engineering and Technology 2021)
Show Figures

Figure 1

Figure 1
<p>Schematic diagram of modeling a three-dimensional (3D) tubular structure in the three-lane OrganoPlate. (<b>A</b>) The three-lane OrganoPlate consists of 40 microfluidic channel units based on a 384-well plate format. After gravity-driven bidirectional perfusion for 10 days, a 3D tubular structure is formed. The basal channel is filled with culture media. (<b>B</b>) Image of 3D reconstruction of a single unit of the kidney-on-a-chip. ECM, extracellular matrix; DAPI, 4′,6-diamidino-2-phenylindole.</p>
Full article ">Figure 2
<p>Viscosity of contrast media according to different iodine concentrations.</p>
Full article ">Figure 3
<p>Mathematical simulation of fluid flow rates and shear stresses of iopromide and iodixanol. (<b>A</b>) Mean flow rate with a rocker interval of 8 min; (<b>B</b>) mean flow rate with a rocker interval of 4 min; (<b>C</b>) mean flow rate with a rocker interval of 2 min; (<b>D</b>) ratio of flow rate (iodixanol to iopromide); (<b>E</b>) fluid shear-stress during a single cycle of rocking. The concentrations of iodixanol and iopromide were selected on the assumption that IOCM is approximately two times more concentrated than LOCM through the renal tubule. (<b>F</b>) Fluid flow rate during a single cycle of rocking.</p>
Full article ">Figure 4
<p>Cell viability according to the different fluid viscosity and shear-stress conditions at (<b>A</b>) static condition, (<b>B</b>) a rocker interval of 8 min, (<b>C</b>) a rocker interval of 4 min, and (<b>D</b>) a rocker interval of 2 min. CM—contrast media; Man—mannitol; HES—hydroxyethyl starch; Con—negative control group. Data are represented as the mean ± SEM. <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 versus control (0 mgI/mL); <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 versus control (0 mgI/mL); ** <span class="html-italic">p</span> &lt; 0.01 versus iopromide group of the same iodine concentration; *** <span class="html-italic">p</span> &lt; 0.001 versus iopromide group of the same iodine concentration.</p>
Full article ">Figure 5
<p>Representative immunoblots of Akt, p-Akt, Erk1/2, p-Erk1/2, and β-actin at (<b>A</b>) a rocker interval of 8 min and (<b>B</b>) a rocker interval of 2 min. (<b>C</b>) Ratio of p-Erk1/2/Erk1/2. (<b>D</b>) Ratio of p-Akt/Akt. Data are represented as the mean ± SEM. * <span class="html-italic">p</span> &lt; 0.05 versus control of 2 min interval, <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 versus control of 8 min interval. LOCM—low-osmolar contrast media; IOCM—iso-osmolar contrast media; Con—control; Man—mannitol; HES—hydroxyethyl starch; N.S.—nonsignificant.</p>
Full article ">Figure 6
<p>Overview of the proposed models of contrast-induced nephropathy. (<b>A</b>) Iso-osmolar contrast media are twice as concentrated as low-osmolar contrast media and have a much greater viscosity. Data from Jost et al. [<a href="#B26-micromachines-13-00688" class="html-bibr">26</a>]. The concentration and viscosity of CM are obtained from an in vitro dialysis model using polyethylene glycol solution with different osmolalities (290, 500, and 1000 mOsm/kg, which represents the mean osmolality of the renal cortex, outer medulla, and inner medulla, respectively). (<b>B</b>) Overall mechanisms of contrast-induced nephropathy. (<b>C</b>) Comparison of iso-osmolar and low-osmolar contrast media in our model. CM—contrast media; LOCM—low-osmolar contrast media; IOCM—iso-osmolar contrast media; GFR—glomerular filtration rate.</p>
Full article ">
19 pages, 2573 KiB  
Article
Efficacy and Safety of Isotonic and Hypotonic Intravenous Maintenance Fluids in Hospitalised Children: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by Norfarahin Hasim, Mimi Azliha Abu Bakar and Md Asiful Islam
Children 2021, 8(9), 785; https://doi.org/10.3390/children8090785 - 8 Sep 2021
Cited by 12 | Viewed by 5729
Abstract
Hyponatraemia is a known complication in hospitalised children receiving maintenance intravenous fluid. Several studies have been published to investigate the efficacy and safety of intravenous fluids in children. However, there is still an ongoing debate regarding the ideal solution to be used in [...] Read more.
Hyponatraemia is a known complication in hospitalised children receiving maintenance intravenous fluid. Several studies have been published to investigate the efficacy and safety of intravenous fluids in children. However, there is still an ongoing debate regarding the ideal solution to be used in the paediatric population. Therefore, the aim of this meta-analysis was to investigate the safety and efficacy of administering isotonic versus hypotonic intravenous maintenance fluid in hospitalised children. An extensive search was undertaken on PubMed, Web of Science, Scopus, ScienceDirect, Google Scholar and Cochrane Library on 28 December 2020. Only randomised controlled trials (RCTs) were included. We used the random-effects model for all analyses. Risk ratio (RR) and mean difference with 95% confidence intervals (CIs) were used for dichotomous and continuous outcomes, respectively. The quality of each study was assessed using the Joanna Briggs Institute critical appraisal tool for RCTs. This study is registered with PROSPERO (CRD42021229067). Twenty-two RCTs with a total of 3795 participants were included. The studies encompassed surgical and medical patients admitted to intensive care unit as well as to general wards. We found that hypotonic fluid significantly increases the risk of hyponatremia at both ≤24 h (RR 0.34; 95% CI: 0.26–0.43, p < 0.00001) and >24 h (RR 0.48; 95% CI: 0.36–0.64, p < 0.00001). Isotonic fluid increases the risk of hypernatraemia at ≤24 h (RR 2.15; 95% CI: 1.24–3.73, p = 0.006). The prevalence of hyponatraemia was also higher in the hypotonic group at both ≤24 h (5.7% vs. 23.3%) and >24 h (6.0% vs. 26.3%). There was no statistically significant difference in the risk of developing adverse outcomes between the two groups. Mean serum and urine sodium as well as serum osmolality/osmolarity was lower in the hypotonic group. Isotonic solution is protective against the development of hyponatraemia while hypotonic solution increases the risk of hyponatraemia. Full article
(This article belongs to the Special Issue Fluid and Electrolyte Therapy in Children)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>PRISMA flow diagram of study selection.</p>
Full article ">Figure 2
<p>Risks of hyponatraemia (<b>A</b>,<b>B</b>) and hypernatraemia (<b>C</b>,<b>D</b>) following isotonic versus hypotonic fluid at ≤24 and &gt;24 h.</p>
Full article ">Figure 2 Cont.
<p>Risks of hyponatraemia (<b>A</b>,<b>B</b>) and hypernatraemia (<b>C</b>,<b>D</b>) following isotonic versus hypotonic fluid at ≤24 and &gt;24 h.</p>
Full article ">Figure 3
<p>Prevalence with 95% CIs of hyponatraemia and hypernatraemia following isotonic and hypotonic fluids in hospitalised children at ≤24 and &gt;24 h.</p>
Full article ">Figure 4
<p>Prevalence with 95% CIs of adverse events following isotonic and hypotonic fluids in hospitalised children.</p>
Full article ">Figure 5
<p>Funnel plots visually representing publication bias assessing risk ratio of (<b>A</b>) hyponatraemia and (<b>B</b>) hypernatraemia.</p>
Full article ">Figure 5 Cont.
<p>Funnel plots visually representing publication bias assessing risk ratio of (<b>A</b>) hyponatraemia and (<b>B</b>) hypernatraemia.</p>
Full article ">
Back to TopTop